Posted on:
With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease. Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated…
Posted on:
Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Posted on:
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study…
Posted on:
We are pleased to announce the successful recipients of our annual Kolling Institute awards program. Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling. The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as…
Posted on:
We would like to congratulate Professor Carol Pollock who has received a highly prestigious award for her extraordinary commitment to research. The International Society of Nephrology has announced Professor Pollock is the 2023 recipient of the Alfred Newton Richards award for outstanding research in the field of nephrology. Carol has welcomed the news. “I am…
Posted on:
Generous funding provided through the Douglas and Lola Douglas scholarship is strengthening evidence around the long term impacts on children born to mothers with obesity and gestational diabetes. Endocrinologist and Kolling Institute researcher Dr Tessa Weir has been able to continue her valuable research as a result of being awarded the scholarship. “I am incredibly grateful…
Posted on:
Kolling researcher and Royal North Shore Hospital endocrinologist Associate Professor Sarah Glastras will have a key role in a national effort to improve long-term outcomes for those with diabetes. The initiative has brought dozens of experts from across the country together under the banner of the Australian Centre for Accelerating Diabetes Innovations Research. International collaborators…
Posted on:
We would like to congratulate Professors Carol Pollock and Gemma Figtree who have received significant National Health and Medical Research Council Investigator Grants. Despite a tremendously competitive field, both clinician/researchers have been awarded $2 million to progress their world-leading research and improve long-term patient outcomes. The announcement highlights the experience and expertise at the Kolling…
Posted on:
Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those…
Category:
Posted on:
Ambitious leadership, functional wellbeing and a passion for collaboration An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve. Highly…
Category:
Copyright © 2026 Kolling Institute
All rights reserved